A phase II trial of concurrent chemoradiotherapy with weekly docetaxel plus cisplatin treatment for unresectable locally advanced head and neck cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2016.09.015 ◽

2017 ◽

Vol 122 (2) ◽

pp. 217-223

Author(s):

Ji Yun Lee ◽

Jong-Mu Sun ◽

Dongryul Oh ◽

Sung Hee Lim ◽

Sangah Chi ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Head ◽

Weekly Docetaxel

Download Full-text

Faculty Opinions recommendation of Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1123209.580347 ◽

2008 ◽

Author(s):

Ricardo Hitt

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Neck Cancer ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Trial ◽

Advanced Head ◽

Radiotherapy Dose ◽

Download Full-text

Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyy145 ◽

2018 ◽

Vol 49 (1) ◽

pp. 37-41 ◽

Author(s):

Takashi Matsuzuka ◽

Naomi Kiyota ◽

Junki Mizusawa ◽

Tetsuo Akimoto ◽

Masato Fujii ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Clinical Impact ◽

Download Full-text

Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin for locally advanced head and neck cancer: A preliminary result

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.5587 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 5587-5587

Author(s):

J. G. Kim ◽

J. H. Baek ◽

S. K. Sohn ◽

D. H. Kim ◽

S. B. Jeon ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Study ◽

Locally Advanced ◽

Download Full-text

Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.

International Journal of Oncology ◽

10.3892/ijo.17.3.543 ◽

2000 ◽

Author(s):

C Riva ◽

J P Lavieille ◽

S Schmerber ◽

O Cuisnie ◽

E Reyt

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Folinic Acid ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Head ◽

Clinical Survey ◽

Infusion Schedule

Download Full-text

Integration of gefitinib (G), into a concurrent chemoradiation (CRT) regimen followed by G adjuvant therapy in patients with locally advanced head and neck cancer (HNC) - a Phase II Trial

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.5506 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 5506-5506 ◽

Author(s):

E. E. W. Cohen ◽

D. J. Haraf ◽

K. M. Stenson ◽

E. Blair ◽

B. E. Brockstein ◽

...

Keyword(s):

Head And Neck Cancer ◽

Adjuvant Therapy ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Concurrent Chemoradiation ◽

Download Full-text

The GIRAFE phase II trial on MVCT-based “volumes of the day” and “dose of the day” addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer

Clinical and Translational Radiation Oncology ◽

10.1016/j.ctro.2019.02.006 ◽

2019 ◽

Vol 16 ◽

pp. 34-39 ◽

Author(s):

Vincent Esteyrie ◽

Baptiste Gleyzolle ◽

Amélie Lusque ◽

Pierre Graff ◽

Anouchka Modesto ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Adaptive Radiotherapy ◽

Download Full-text

ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial

British Journal of Cancer ◽

10.1038/bjc.2013.576 ◽

2013 ◽

Vol 109 (8) ◽

pp. 2096-2105 ◽

Author(s):

J E Bauman ◽

M C Austin ◽

R Schmidt ◽

B F Kurland ◽

A Vaezi ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Trial ◽

Prognostic Biomarker ◽

Locally Advanced ◽

Download Full-text

4-Year Results of a Phase II Trial Using Hyperfractionated Accelerated Radiation with Concurrent Once-Weekly cis-Platinum and 5-FU (C-HART) in Locally Advanced Head and Neck Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2007.06.003 ◽

2007 ◽

Vol 69 (2) ◽

pp. S136

Author(s):

V.G.F.A. Budach ◽

H. Badakhshi ◽

D. Boehmer ◽

L. Schlenger ◽

K. WerNecke

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Download Full-text

Chemo-radiotherapy for locally advanced head and neck cancer—long-term results of a phase II trial

European Journal of Cancer ◽

10.1016/s0959-8049(97)00099-3 ◽

1997 ◽

Vol 33 (7) ◽

pp. 1152-1155 ◽

Author(s):

S. Dinges ◽

V. Budach ◽

M. Stuschke ◽

W. Budach ◽

D. Boehmer ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Long Term Results ◽

Download Full-text

Results of a phase-ii trial using hyperfractionated accelerated radiation with concurrent cis-platinum/5-FU (C-HART) in locally advanced head and neck cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(04)01764-x ◽

2004 ◽

Vol 60 ◽

pp. S514-S514

Author(s):

H BADAKHSHI ◽

D BOEHMER ◽

L MOSER ◽

L SCHLENGER ◽

K WERNECKE ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Download Full-text